Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Correlation between spirometric findings and 6-min walk test in patients with chronic obstructive pulmonary disease

View through CrossRef
Background: Chronic obstructive pulmonary disease (COPD) is characterized by permanent respiratory symptoms and limitation of airflow which is due to airway and/or alveolar abnormalities, caused by significant exposure to noxious particles or gases. COPD is a common, preventable, and treatable disease. The present study was undertaken to correlate the spirometric values with the result of 6MWT and to assess whether 6MWT can be used as an alternative test to spirometry in predicting the severity of COPD. Aims and Objectives: The present study observed correlate the spirometric values with result of 6-min walk test (6MWT). Materials and Methods: A total of 40 male and female COPD patients within the age group of 25–75 years of were part of the study. Spirometric indices forced expiratory volume 1 s(FEV1), %FEV1, forced vital capacity (FVC), FEV1/FVC ratio were recorded. Soon after the spirometry, the subjects were subjected to 6MWT. 6MWT was performed on a 30 m stretch. Distance walked in 6 min was recorded in meters. Predicted 6-min walk distance (6MWD) (For males)=561.022-(2.507×age {years})+(1.505×weight {kg})-(0.055×height {cm}) Predicted 6-min walk distance(for females)=30.325–(0.809×age {years})-(2.074×weight {kg})+(4.235×height {cm}) Patients were divided into normal (> 80%), mild impairment (60–79%), moderate impairment (40–59%), and severe impairment (<40%). Results: Out of 40 participants, there were 15 females and 25 male participants. In age group of 25–35 years -2 males, 36–45 years-9 patients (6 females and 3 males), 46–55 years -10 cases (5 females and 5 males), 56–65 years -13 patients (3 females and 10 males), 66–75 years- 6 patients(1 female and 5 males. Correlation of 6MWD with FEV1 (P=0.00026), FEV1% predicted (P=0.000), FVC (P=0.00096), FEV1/FVC (0.001). Correlation of % predicted 6MWD with FEV1 (P=0.001), FEV1 %predicted (P=0.000), FVC (P=0.002), FEV1/FVC (0.006). There is significant positive correlation of 6MWD and % predicted 6MWD with FEV1, FEV1 predicted value, FVC, and FEV1/FVC. Conclusion: The study results provide additional evidence that the 6MWT is a simple reproducible, inexpensive test to assess the patient’s functional capacity in the south Indian population. Further detailed studies are recommended in this area.
Title: Correlation between spirometric findings and 6-min walk test in patients with chronic obstructive pulmonary disease
Description:
Background: Chronic obstructive pulmonary disease (COPD) is characterized by permanent respiratory symptoms and limitation of airflow which is due to airway and/or alveolar abnormalities, caused by significant exposure to noxious particles or gases.
COPD is a common, preventable, and treatable disease.
The present study was undertaken to correlate the spirometric values with the result of 6MWT and to assess whether 6MWT can be used as an alternative test to spirometry in predicting the severity of COPD.
Aims and Objectives: The present study observed correlate the spirometric values with result of 6-min walk test (6MWT).
Materials and Methods: A total of 40 male and female COPD patients within the age group of 25–75 years of were part of the study.
Spirometric indices forced expiratory volume 1 s(FEV1), %FEV1, forced vital capacity (FVC), FEV1/FVC ratio were recorded.
Soon after the spirometry, the subjects were subjected to 6MWT.
6MWT was performed on a 30 m stretch.
Distance walked in 6 min was recorded in meters.
Predicted 6-min walk distance (6MWD) (For males)=561.
022-(2.
507×age {years})+(1.
505×weight {kg})-(0.
055×height {cm}) Predicted 6-min walk distance(for females)=30.
325–(0.
809×age {years})-(2.
074×weight {kg})+(4.
235×height {cm}) Patients were divided into normal (> 80%), mild impairment (60–79%), moderate impairment (40–59%), and severe impairment (<40%).
Results: Out of 40 participants, there were 15 females and 25 male participants.
In age group of 25–35 years -2 males, 36–45 years-9 patients (6 females and 3 males), 46–55 years -10 cases (5 females and 5 males), 56–65 years -13 patients (3 females and 10 males), 66–75 years- 6 patients(1 female and 5 males.
Correlation of 6MWD with FEV1 (P=0.
00026), FEV1% predicted (P=0.
000), FVC (P=0.
00096), FEV1/FVC (0.
001).
Correlation of % predicted 6MWD with FEV1 (P=0.
001), FEV1 %predicted (P=0.
000), FVC (P=0.
002), FEV1/FVC (0.
006).
There is significant positive correlation of 6MWD and % predicted 6MWD with FEV1, FEV1 predicted value, FVC, and FEV1/FVC.
Conclusion: The study results provide additional evidence that the 6MWT is a simple reproducible, inexpensive test to assess the patient’s functional capacity in the south Indian population.
Further detailed studies are recommended in this area.

Related Results

Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Objective: To determine the health-related quality of life among patients suffering from chronic obstructive pulmonary disease. Study Design: Cross sectional analytical study. Plac...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract Introduction Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
CONTINUOUS COMPRESSION WITHOUT DEFIBRILLATION FAVOURED NO SHORT-TERM SURVIVAL IN PROLONGED VENTRICULAR FIBRILLATION
CONTINUOUS COMPRESSION WITHOUT DEFIBRILLATION FAVOURED NO SHORT-TERM SURVIVAL IN PROLONGED VENTRICULAR FIBRILLATION
Objectives Aims: During the 2005 American Heart Association (AHA) Consensus Conference, compression first versus defibrillation first for sudden cardiac arrest wi...
Investigating fibrinogen levels as a biomarker for immune inflammation severity in COPD patients across GOLD stages
Investigating fibrinogen levels as a biomarker for immune inflammation severity in COPD patients across GOLD stages
Objective: To assess the association between fibrinogen levels and immune inflammation severity in patients with chronic obstructive pulmonary disease at different stages of the Gl...
Pulmonary hypertension within individuals suffering from chronic obstructive pulmonary disease.
Pulmonary hypertension within individuals suffering from chronic obstructive pulmonary disease.
Objective: To establish the frequency in regards to pulmonary hypertension within individuals suffering from chronic obstructive pulmonary disease. Study Design: Cross-sectional st...
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
FREQUENCY OF PULMONARY HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRESENTING AT TERTIARY CARE HOSPITAL
FREQUENCY OF PULMONARY HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE PRESENTING AT TERTIARY CARE HOSPITAL
Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder frequently complicated by pulmonary hypertension (PH), a condition associated with in...

Back to Top